{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:27:21Z","timestamp":1787376441022,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69028-9","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T03:02:27Z","timestamp":1723604547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K\/AKT\/NF-\u03baB signaling pathway"],"prefix":"10.1038","volume":"14","author":[{"given":"Wenbo","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"69028_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/BF00145007","volume":"7","author":"A Hofman","year":"1991","unstructured":"Hofman, A., Grobbee, D. E., de Jong, P. T. & van den Ouweland, F. A. Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur. J. Epidemiol. 7, 403\u2013422 (1991).","journal-title":"Eur. J. Epidemiol."},{"key":"69028_CR2","first-page":"376","volume":"6","author":"SR Goldring","year":"2006","unstructured":"Goldring, S. R. & Goldring, M. B. Clinical aspects, pathology and pathophysiology of osteoarthritis. J. Musculoskelet. Neuronal Interact. 6, 376\u2013378 (2006).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"69028_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.blo.0000131233.83640.91","volume":"423","author":"F Guilak","year":"2004","unstructured":"Guilak, F. et al. The role of biomechanics and inflammation in cartilage injury and repair. Clin. Orthop. Relat. Res. 423, 17\u201326 (2004).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"69028_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1759720X12467868","volume":"5","author":"J Sokolove","year":"2013","unstructured":"Sokolove, J. & Lepus, C. M. Role of inflammation in the pathogenesis of osteoarthritis: Latest findings and interpretations. Ther. Adv. Musculoskelet. Dis. 5, 77\u201394 (2013).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"69028_CR5","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/01.blo.0000144854.66565.8f","volume":"427","author":"SR Goldring","year":"2004","unstructured":"Goldring, S. R. & Goldring, M. B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. 427, S27\u2013S36 (2004).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"69028_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/s10165-006-0490-6","volume":"16","author":"T Yasuda","year":"2006","unstructured":"Yasuda, T. Cartilage destruction by matrix degradation products. Mod. Rheumatol. 16, 197\u2013205 (2006).","journal-title":"Mod. Rheumatol."},{"key":"69028_CR7","doi-asserted-by":"publisher","first-page":"6681352","DOI":"10.1155\/2020\/6681352","volume":"2020","author":"Z Deng","year":"2020","unstructured":"Deng, Z. et al. Pharmacological activity of eriodictyol: The major natural polyphenolic flavanone. Evid. Based Complement. Altern. Med. 2020, 6681352 (2020).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"69028_CR8","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3892\/etm.2015.2827","volume":"10","author":"GF Zhu","year":"2015","unstructured":"Zhu, G. F., Guo, H. J., Huang, Y., Wu, C. T. & Zhang, X. F. Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity. Exp. Ther. Med. 10, 2259\u20132266 (2015).","journal-title":"Exp. Ther. Med."},{"key":"69028_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s12272-011-0418-3","volume":"34","author":"JK Lee","year":"2011","unstructured":"Lee, J. K. Anti-inflammatory effects of eriodictyol in lipopolysaccharide-stimulated raw 264.7 murine macrophages. Arch. Pharm. Res. 34, 671\u2013679 (2011).","journal-title":"Arch. Pharm. Res."},{"key":"69028_CR10","doi-asserted-by":"publisher","first-page":"68668","DOI":"10.18632\/oncotarget.19822","volume":"8","author":"G Xie","year":"2017","unstructured":"Xie, G., Meng, X., Wang, F., Bao, Y. & Huo, J. Eriodictyol attenuates arsenic trioxide-induced liver injury by activation of Nrf2. Oncotarget 8, 68668\u201368674 (2017).","journal-title":"Oncotarget"},{"key":"69028_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fphar.2018.00033","volume":"9","author":"D Li","year":"2018","unstructured":"Li, D. et al. Eriodictyol attenuates myocardial ischemia-reperfusion injury through the activation of JAK2. Front. Pharmacol. 9, 33 (2018).","journal-title":"Front. Pharmacol."},{"key":"69028_CR12","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/jcp.25304","volume":"231","author":"F Song","year":"2016","unstructured":"Song, F. et al. Eriodictyol inhibits RANKL-induced osteoclast formation and function via inhibition of NFATc1 activity. J. Cell. Physiol. 231, 1983\u20131993 (2016).","journal-title":"J. Cell. Physiol."},{"key":"69028_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10020-024-00819-6","volume":"30","author":"W Gao","year":"2024","unstructured":"Gao, W. et al. CHMP5 attenuates osteoarthritis via inhibiting chondrocyte apoptosis and extracellular matrix degradation: Involvement of NF-kappaB pathway. Mol. Med. 30, 55 (2024).","journal-title":"Mol. Med."},{"key":"69028_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.joca.2010.10.019","volume":"19","author":"AWM Cheng","year":"2011","unstructured":"Cheng, A. W. M., Stabler, T. V., Bolognesi, M. & Kraus, V. B. Selenomethionine inhibits IL-1 beta inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes. Osteoarthr. Cartil. 19, 118\u2013125 (2011).","journal-title":"Osteoarthr. Cartil."},{"key":"69028_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125776","volume":"10","author":"C Ma","year":"2015","unstructured":"Ma, C. et al. The role of PPAR gamma in advanced glycation end products-induced inflammatory response in human chondrocytes. PLoS ONE 10, e0125776 (2015).","journal-title":"PLoS ONE"},{"key":"69028_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18228","volume":"28","author":"JY Sun","year":"2024","unstructured":"Sun, J. Y., Song, X. J., Wang, C. J. & Ruan, Q. Geniposidic acid alleviates osteoarthritis progression through inhibiting inflammation and chondrocytes ferroptosis. J. Cell. Mol. Med. 28, e18228 (2024).","journal-title":"J. Cell. Mol. Med."},{"key":"69028_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122117","volume":"332","author":"JY Sun","year":"2023","unstructured":"Sun, J. Y., Zhang, Y. F., Wang, C. J. & Ruan, Q. Kukoamine A protects mice against osteoarthritis by inhibiting chondrocyte inflammation and ferroptosis via SIRT1\/GPX4 signaling pathway. Life Sci. 332, 122117 (2023).","journal-title":"Life Sci."},{"key":"69028_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10753-016-0309-3","volume":"39","author":"C Wang","year":"2016","unstructured":"Wang, C., Zeng, L., Zhang, T., Liu, J. & Wang, W. Tenuigenin prevents IL-1beta-induced inflammation in human osteoarthritis chondrocytes by suppressing PI3K\/AKT\/NF-kappaB signaling pathway. Inflammation 39, 807\u2013812 (2016).","journal-title":"Inflammation"},{"key":"69028_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bcp.2014.05.004","volume":"90","author":"YH Fu","year":"2014","unstructured":"Fu, Y. H. et al. Cyanidin-3-O-beta-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts. Biochem. Pharmacol. 90, 126\u2013134 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"69028_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/med.21990","volume":"44","author":"AT Rufino","year":"2024","unstructured":"Rufino, A. T. et al. Rheumatoid arthritis molecular targets and their importance to flavonoid-based therapy. Med. Res. Rev. 44, 497\u2013538 (2024).","journal-title":"Med. Res. Rev."},{"key":"69028_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/bdd.588","volume":"29","author":"JA Y\u00e1\u00f1ez","year":"2008","unstructured":"Y\u00e1\u00f1ez, J. A. et al. Pharmacokinetics of selected chiral flavonoids: Hesperetin, naringenin and eriodictyol in rats and their content in fruit juices. Biopharm. Drug Dispos. 29, 63\u201382 (2008).","journal-title":"Biopharm. Drug Dispos."},{"key":"69028_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/561459","volume":"2014","author":"P Wojdasiewicz","year":"2014","unstructured":"Wojdasiewicz, P., Poniatowski, L. A. & Szukiewicz, D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediat. Inflamm. 2014, 561459 (2014).","journal-title":"Mediat. Inflamm."},{"key":"69028_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J. P. & Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33\u201342 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"69028_CR24","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3899\/jrheum.080346","volume":"35","author":"M Daheshia","year":"2008","unstructured":"Daheshia, M. & Yao, J. Q. The interleukin 1beta pathway in the pathogenesis of osteoarthritis. J. Rheumatol. 35, 2306\u20132312 (2008).","journal-title":"J. Rheumatol."},{"key":"69028_CR25","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s10753-017-0630-5","volume":"40","author":"T Jia","year":"2017","unstructured":"Jia, T., Qiao, J., Guan, D. & Chen, T. Anti-inflammatory effects of licochalcone A on IL-1beta-stimulated human osteoarthritis chondrocytes. Inflammation 40, 1894\u20131902 (2017).","journal-title":"Inflammation"},{"key":"69028_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1063-4584(03)00150-X","volume":"11","author":"YE Henrotin","year":"2003","unstructured":"Henrotin, Y. E., Bruckner, P. & Pujol, J. P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 11, 747\u2013755 (2003).","journal-title":"Osteoarthr. Cartil."},{"key":"69028_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00005-016-0405-y","volume":"64","author":"A Panday","year":"2016","unstructured":"Panday, A. et al. Transcription factor NF-kappaB: An update on intervention strategies. Arch. Immunol. Ther. Exp. (Warsz) 64, 463\u2013483 (2016).","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"69028_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.intimp.2018.06.041","volume":"62","author":"D Wu","year":"2018","unstructured":"Wu, D. et al. Sauchinone inhibits IL-1beta induced catabolism and hypertrophy in mouse chondrocytes to attenuate osteoarthritis via Nrf2\/HO-1 and NF-kappaB pathways. Int. Immunopharmacol. 62, 181\u2013190 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"69028_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/138945010791011938","volume":"11","author":"KB Marcu","year":"2010","unstructured":"Marcu, K. B., Otero, M., Olivotto, E., Borzi, R. M. & Goldring, M. B. NF-kappaB signaling: Multiple angles to target OA. Curr. Drug Targets 11, 599\u2013613 (2010).","journal-title":"Curr. Drug Targets"},{"key":"69028_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","volume":"14","author":"JA Roman-Blas","year":"2006","unstructured":"Roman-Blas, J. A. & Jimenez, S. A. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr. Cartil. 14, 839\u2013848 (2006).","journal-title":"Osteoarthr. Cartil."},{"key":"69028_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.joca.2020.02.027","volume":"28","author":"K Sun","year":"2020","unstructured":"Sun, K. et al. The PI3K\/AKT\/mTOR signaling pathway in osteoarthritis: A narrative review. Osteoarthr. Cartil. 28, 400\u2013409 (2020).","journal-title":"Osteoarthr. Cartil."},{"key":"69028_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bone.2008.02.009","volume":"42","author":"C Dufour","year":"2008","unstructured":"Dufour, C. et al. FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K\/Akt signaling and osteoblast survival. Bone 42, 1032\u20131039 (2008).","journal-title":"Bone"},{"key":"69028_CR33","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.3390\/molecules25143164","volume":"25","author":"MK Ediriweera","year":"2020","unstructured":"Ediriweera, M. K., Moon, J. Y., Nguyen, Y. T. K. & Cho, S. K. 10-Gingerol targets lipid rafts associated PI3K\/Akt signaling in radio-resistant triple negative breast cancer cells. Molecules 25, 3164 (2020).","journal-title":"Molecules"},{"key":"69028_CR34","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/me.2002-0399","volume":"17","author":"X Hu","year":"2003","unstructured":"Hu, X., Li, S. Z., Wu, J., Xia, C. S. & Lala, D. S. Liver X receptors interact with corepressors to regulate gene expression. Mol. Endocrinol. 17, 1019\u20131026 (2003).","journal-title":"Mol. Endocrinol."},{"key":"69028_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1074\/jbc.M110.179499","volume":"286","author":"BM Stenson","year":"2011","unstructured":"Stenson, B. M. et al. Liver X receptor (LXR) regulates human adipocyte lipolysis. J. Biol. Chem. 286, 370\u2013379 (2011).","journal-title":"J. Biol. Chem."},{"key":"69028_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrd4280","volume":"13","author":"C Hong","year":"2014","unstructured":"Hong, C. & Tontonoz, P. Liver X receptors in lipid metabolism: Opportunities for drug discovery. Nat. Rev. Drug Discov. 13, 433\u2013444 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"69028_CR37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/15384101.2022.2042777","volume":"21","author":"L Chen","year":"2022","unstructured":"Chen, L., Zhao, Z. W., Zeng, P. H., Zhou, Y. J. & Yin, W. J. Molecular mechanisms for ABCA1-mediated cholesterol efflux. Cell Cycle 21, 1121\u20131139 (2022).","journal-title":"Cell Cycle"},{"key":"69028_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2174\/138920101131400228","volume":"14","author":"CX Huang","year":"2013","unstructured":"Huang, C. X. & Zhang, Y. L. The target of regulating the ATP-binding cassette A1 protein (ABCA1): Promoting ABCA1-mediated cholesterol efflux in different cells. Curr. Pharm. Biotechnol. 14, 623\u2013631 (2013).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"69028_CR39","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1002\/jcp.30204","volume":"236","author":"L Zhao","year":"2021","unstructured":"Zhao, L. et al. The roles of liver X receptor \u03b1 in inflammation and inflammation-associated diseases. J. Cell. Physiol. 236, 4807\u20134828 (2021).","journal-title":"J. Cell. Physiol."},{"key":"69028_CR40","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.freeradbiomed.2015.10.407","volume":"89","author":"YH Fu","year":"2015","unstructured":"Fu, Y. H., Hu, X. Y., Cao, Y. G., Zhang, Z. C. & Zhang, N. S. Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts. Free Radic. Biol. Med. 89, 777\u2013785 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"69028_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08009","volume":"4","author":"A Ito","year":"2015","unstructured":"Ito, A. et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. Elife 4, e08009 (2015).","journal-title":"Elife"}],"updated-by":[{"DOI":"10.1038\/s41598-024-74713-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69028-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69028-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69028-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T13:04:22Z","timestamp":1728565462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69028-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69028"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69028-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-74713-w","URL":"https:\/\/doi.org\/10.1038\/s41598-024-74713-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18853"}}